Enara Bio
PrivateLast Round
Series B
Oct 3, 2024
Total Funding Raised
$84.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Enara Bio is a biotechnology company that develops cancer immunotherapies by utilizing its proprietary platforms to discover and validate novel cancer-specific targets known as Dark Antigens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enara Bio Comparables
Compare Enara Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| T-Therapeutics | 84% | |
| T-Knife | 81% | |
| BlueSphere Bio | 79% | |
Enara Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 3, 2024 | ||||
| Series A | Nov 6, 2019 |
Key People
Founding team and executive leadership
Enara Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B, Series A, Series A Extension |
| SV Health Investors | Series B, Series A Extension, Series A |
| M Ventures | Series B |
| The Francis Crick Institute | Series B |
| Pfizer Ventures | Series B |
| Samsara BioCapital | Series B, Series A, Series A Extension |
| Pfizer Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 81% MoM, reaching 3.5K.
- Mar 18, 2026
New data on lead candidate ENA101 to be presented, targeting novel cancer antigen.
Enara Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enara Bio's valuation, stock price, and market status.